From the Editor

New analyses of results from the SPRINT trial1 continue to pour in. In a recent analysis, Markovitz et  al2 explored the incremental effects of the serial addition of a new class of antihypertensive medication on blood pressure lowering. The novelty of their approach was the use of instrumental variable analysis, which used a patient's randomization status (standard therapy to systolic blood pressur e

Source: Journal of the American Society of Hypertension - February 6, 2018 Category: Cardiology Authors: Daniel Levy Tags: Editor's Page Source Type: research